Core Points - The aquaculture sector experienced a decline of 1.31% on October 30, with Tianyu Biology leading the drop [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Stock Performance - Yisheng Co. (002458) closed at 9.03, up 0.33% with a trading volume of 97,800 shares and a turnover of 88.43 million yuan [1] - Xiantan Co. (002746) closed at 6.31, up 0.32% with a trading volume of 154,800 shares and a turnover of 97.81 million yuan [1] - Tianyu Biology (603717) closed at 8.73, down 3.64% with a trading volume of 155,200 shares and a turnover of 137 million yuan [2] - Huaying Agriculture (002321) closed at 2.77, down 3.15% with a trading volume of 424,400 shares and a turnover of 119 million yuan [2] Capital Flow - The aquaculture sector saw a net outflow of 188 million yuan from institutional investors, while retail investors had a net inflow of 141 million yuan [2] - The main capital inflow and outflow for specific stocks included: - Jingji Zhinnong (000048) had a net inflow of 19.99 million yuan from main capital [3] - Wens Foodstuff Group (300498) had a net inflow of 7.96 million yuan from main capital [3] - Yisheng Co. (002458) had a net inflow of 3.79 million yuan from main capital [3]

Group 1 - *ST Tianshan reported a revenue of approximately 58.48 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 44.98% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 11.7 million yuan [1] - The basic earnings per share showed a loss of 0.0374 yuan [1] Group 2 - As of the report, the market capitalization of *ST Tianshan is 2.6 billion yuan [2] - The Chinese innovative drug sector has generated 80 billion US dollars in overseas licensing this year [2] - There is a contrast in the biopharmaceutical secondary market being active while the primary market is facing challenges in fundraising [2]

Group 1 - The core point of the article is that *ST Tianshan announced the transfer of its 100% stake in Baluruk Livestock Co., Ltd. to Xiamen Yunjihuo Enterprise Network Technology Co., Ltd. for a nominal price of 1 RMB due to the poor long-term operating conditions of Baluruk and its insolvency [1] - The decision is part of the company's strategy to optimize its asset structure and focus on core business operations [1] - As of the first half of 2025, *ST Tianshan's revenue composition is 54.91% from the livestock industry and 45.09% from asset leasing [1] Group 2 - As of the report, *ST Tianshan has a market capitalization of 2.6 billion RMB [2] - The article highlights the booming secondary market for biopharmaceuticals in China, with 80 billion USD in overseas licensing deals this year [2] - There is a contrast noted between the hot secondary market and the cooling fundraising environment in the primary market for biopharmaceuticals [2]

新疆天山畜牧生物工程股份有限公司 第六届董事会独立董事专门会议第一次会议决议 新疆天山畜牧生物工程股份有限公司（以下简称"公司"）第六届董事会独 立董事专门会议第一次会议（以下简称"本次会议"）通知及会议材料于 2025 年 10 月 17 日以书面通知和电子邮件方式发出，于 2025 年 10 月 21 日以通讯表 决方式召开。本次会议经公司全体独立董事推举由独立董事刘宗柳先生主持，应 到独立董事 3 人，实到独立董事 3 人。 本次会议的通知、召集、召开和表决程序符合《中华人民共和国公司法》《上 市公司独立董事管理办法》《公司章程》《公司独立董事专门会议工作制度》等 有关规定，会议合法有效。 经与会独立董事审议，以记名投票表决方式审议通过了如下议案： 审议通过《关于转让全资孙公司股权暨关联交易的议案》 二〇二五年十月二十一日 经审核，独立董事认为：本次公司转让新疆巴尔鲁克牧业有限责任公司 100% 股权暨关联交易事项符合公司的发展利益和业务需要，符合公司及股东利益，不 存在损害公司特别是中小投资者利益的行为。同时，公司应遵照《深圳证券交易 所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 ...

证券代码：300313 证券简称：*ST天山 公告编号：2025-060 新疆天山畜牧生物工程股份有限公司 第六届董事会第二次会议决议公告 表决结果：同意 9 票、反对 0 票、弃权 0 票。此议案获得通过。 具体内容详见公司同日在中国证监会指定的创业板信息披露网站巨潮资讯 网（www.cninfo.com.cn）发布的《2025 年第三季度报告》。 1 新疆天山畜牧生物工程股份有限公司（以下简称"公司"）第六届董事会第 二次会议（以下简称"本次会议"）通知及会议材料于 2025 年 10 月 21 日以书 面通知和电子邮件方式发出。本次会议于 2025 年 10 月 24 日以通讯表决方式召 开，本次会议应参加董事 9 人，实际参加董事 9 人。本次会议的通知、召开、召 集和表决程序符合《中华人民共和国公司法》及《新疆天山畜牧生物工程股份有 限公司章程》的有关规定，会议决议合法、有效。 二、董事会会议审议情况 本次会议以记名方式投票表决，审议通过以下事项： （一）审议通过《公司 2025 年第三季度报告》 经审议，董事会认为《公司 2025 年第三季度报告》符合相关法律法规和深 圳证券交易所的规定，真实、准 ...

Financial Performance - The company's operating revenue for the third quarter was ¥16,866,279.73, a decrease of 71.41% compared to the same period last year[5] - The net profit attributable to shareholders was -¥3,902,570.15, representing a 71.70% increase in losses year-over-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥4,108,249.94, a 69.39% increase in losses compared to the previous year[5] - The company reported total operating revenue of ¥58,478,285.53, a decrease of 45% compared to ¥106,287,698.79 in the previous period[46] - The company’s total liabilities decreased to ¥232,942,500.82 from ¥242,514,811.12[44] - The company’s equity attributable to shareholders improved to ¥34,393,812.61 from a negative equity of -¥3,779,268.32[44] - The net profit for the current period is -10,963,990.77, compared to -40,929,503.15 in the previous period, showing an improvement[47] - Basic and diluted earnings per share are both -0.0374, compared to -0.1330 in the previous period[48] - The total operating profit (loss) is -7,578,710.70, an improvement from -35,615,837.42 in the previous period[47] - The company reported a total comprehensive income of -10,963,990.77, compared to -40,929,503.15 in the previous period, indicating a significant reduction in losses[47] Assets and Liabilities - Total assets at the end of the reporting period were ¥277,533,099.71, an increase of 11.82% from the end of the previous year[5] - Current assets totaled ¥95,486,736.89, up from ¥62,540,010.51 at the start of the period[42] - The company's cash and cash equivalents decreased to ¥8,739,557.55 from ¥24,500,019.79[42] - The company’s inventory increased significantly to ¥68,340,601.27 from ¥18,468,103.62[43] - Cash and cash equivalents at the end of the period stand at 8,739,557.55, down from 14,044,848.48 in the previous period, a decrease of approximately 37.5%[49] Cash Flow - The company's cash flow from operating activities showed a net outflow of -¥51,013,529.64, a significant decline of 1,444.49% year-to-date[5] - Cash inflow from operating activities decreased by 40.96% to ¥66,725,423.73, attributed to lower sales revenue from live livestock[13] - Cash flow from operating activities shows a net outflow of -51,013,529.64, a significant decline from a net inflow of 3,794,254.51 in the previous period[48] - Investment activities resulted in a net cash outflow of -846,261.03, compared to a net inflow of 417,117.37 in the previous period[49] - The company raised 40,000,000.00 in cash from borrowings, compared to 122,500,000.00 in the previous period, indicating a decrease of about 67.3%[49] Shareholder Information - Total number of common shareholders at the end of the reporting period is 11,496[15] - The largest shareholder, Xinjiang Tianshan Animal Husbandry Biotechnology Co., Ltd., holds 23.39% of shares, totaling 73,198,402 shares[15] - The second-largest shareholder, Huzhou Haohui Enterprise Management Consulting Co., Ltd., holds 22.11% of shares, totaling 69,211,312 shares[15] - The third-largest shareholder, Chen Dehong, holds 10.95% of shares, totaling 34,279,083 shares, with 33,509,768 shares pledged[15] - Xinjiang Animal Husbandry Group Co., Ltd. holds 10.55% of shares, totaling 33,025,998 shares[15] - The total number of shares held by the top 10 shareholders accounts for a significant portion of the company's equity[15] - The company has not reported any changes in the participation of major shareholders in margin financing and securities lending[15] - There are no preferred shareholders or changes in restricted shares reported for this period[16] - The company has a total of 53,861,312 shares (17.21% of total shares) with voting rights entrusted to Xiamen Shed[15] - The report indicates that there are no significant changes in the status of restricted shares for major shareholders[17] Legal and Strategic Developments - The company is currently involved in multiple legal proceedings regarding the execution of pledged shares, with some cases still under review[31][33][35] - The company plans to liquidate its subsidiary, Ningxia Meijia Agricultural Biotechnology Development Co., Ltd., due to unclear strategic direction and consecutive years of losses[39] Government Subsidies - The company received government subsidies amounting to ¥3,684,506.76, a 573.92% increase compared to the previous year[11] Impairment and Costs - The company recognized an impairment provision of ¥28,690,000 due to changes in the agricultural technology production environment[37] - Total operating costs were ¥71,393,105.79, down 47% from ¥135,898,039.38 in the prior period[46]

证券代码：300313 证券简称：*ST天山 公告编号：2025-062 新疆天山畜牧生物工程股份有限公司 关于转让全资孙公司股权暨关联交易的公告 （二）关联关系说明 本次股权受让方厦门云集货企，系公司实际控制人陈明艺、陈欢夫妇控制下 的公司。根据《深圳证券交易所创业板股票上市规则》《公司章程》《关联交易 管理制度》等相关规定，为公司关联法人，本次交易构成关联交易。 （三）审议情况 公司于 2025 年 10 月 24 日召开第六届董事会第二次会议，审议通过《关于 转让全资孙公司股权暨关联交易的议案》，关联董事陈明艺、杨昀、陈杰已回避 表决，非关联董事以 6 票同意，0 票反对，0 票弃权的表决结果审议通过。 1 本议案提交董事会审议前，已经公司第六届董事会独立董事专门会议第一次 会议审议通过，全体独立董事一致同意将该议案提交董事会审议。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 新疆天山畜牧生物工程股份有限公司（以下简称"公司"或"上市公司"） 于 2025 年 10 月 24 日召开了第六届董事会第二次会议，审议通过了《关于转让 全资孙公司股权暨关联 ...

Core Insights - The aquaculture sector experienced a slight decline of 0.08% on October 24, with Xiaoming Co. leading the drop [1] - The Shanghai Composite Index closed at 3950.31, up 0.71%, while the Shenzhen Component Index closed at 13289.18, up 2.02% [1] Aquaculture Sector Performance - Yisheng Co. (002458) saw a closing price of 8.85, with an increase of 2.67% and a trading volume of 150,400 shares, totaling a transaction value of 134 million yuan [1] - Shengnong Development (002299) closed at 16.28, up 1.12%, with a trading volume of 136,800 shares and a transaction value of 222 million yuan [1] - Other notable performances include: - ST Tianshan (300313) at 8.43, up 0.60% [1] - Jinjidun Agricultural (000048) at 17.03, up 0.53% [1] - Muyuan Foods (002714) at 48.86, up 0.31% [1] - Xiaoming Co. (300967) led the decline with a closing price of 21.20, down 3.02% [2] Capital Flow Analysis - The aquaculture sector saw a net outflow of 153 million yuan from institutional investors, while retail investors contributed a net inflow of 11.67 million yuan [2] - Notable capital flows include: - Luoniushan (000735) with a net inflow of 5.14 million yuan from institutional investors [3] - Yike Foods (301116) with a net outflow of 1.90 million yuan from institutional investors [3] - Yisheng Co. (002458) experienced a net outflow of 2.22 million yuan from institutional investors [3]

Core Insights - The aquaculture sector experienced a slight increase of 0.28% on October 23, with Xiaoming Co. leading the gains [1] - The Shanghai Composite Index closed at 3922.41, up 0.22%, while the Shenzhen Component Index closed at 13025.45, also up 0.22% [1] Aquaculture Sector Performance - Xiaoming Co. (300967) closed at 21.86, up 2.82% with a trading volume of 105,300 shares and a transaction value of 230 million [1] - Tianyu Biological (603717) closed at 9.17, up 2.12% with a trading volume of 152,700 shares and a transaction value of 140 million [1] - Other notable performers include Xiangjia Co. (002982) up 1.76%, Minhe Co. (002234) up 1.73%, and Xinwufeng (600975) up 1.57% [1] Capital Flow Analysis - The aquaculture sector saw a net inflow of 25.81 million from institutional investors, while retail investors contributed a net inflow of 4.57 million [2] - Major stocks like Jingji Zhino (000048) experienced a significant net outflow of 29.90 million from speculative funds [3] - Muyu Co. (002714) had a net inflow of 43.02 million from institutional investors, but also saw a net outflow of 26.25 million from speculative funds [3]

Group 1 - High Energy Environment reported a net profit of 646 million yuan for the first three quarters, a year-on-year increase of 15.18% [1] - Tianzhun Technology received approval from the China Securities Regulatory Commission for issuing convertible bonds to unspecified objects [1] - Energy Conservation Wind Power achieved a cumulative power generation of 9.349 billion kWh, a year-on-year increase of 1.72% [1][2] Group 2 - Sichuan Road and Bridge's total amount of projects won in the first three quarters reached 97.173 billion yuan, a year-on-year increase of 25.16% [3] - Shaanxi Energy's power generation in the third quarter decreased by 1% year-on-year, while its coal sales increased by 136.98% [3][4] Group 3 - Jintuo Co. announced that four shareholders plan to reduce their holdings by up to 2.95% of the company's shares [5] - Tailin Microelectronics expects a net profit increase of 118% year-on-year for the first three quarters, with revenue of approximately 766 million yuan [6] - Asia-Pacific Co. anticipates a net profit of 310 million to 335 million yuan for the first three quarters, a year-on-year increase of 97.38% to 113.30% [8] Group 4 - He Sheng New Materials expects a net profit increase of 60% to 80% for the first three quarters, with a projected profit of 137 million to 154 million yuan [9] - Spring Airlines reported a passenger turnover of 4.835 billion person-kilometers in September, a year-on-year increase of 22.87% [10][11] Group 5 - Mingxin Xuteng received a notification from a leading new energy vehicle company for a project worth approximately 650 million yuan [12] - Acolyte's subsidiary received a government subsidy of 47.13 million yuan for fixed asset investment [13] Group 6 - Fangsheng Pharmaceutical's subsidiary received approval for clinical trials of a new drug for treating advanced prostate cancer [14] - Aofu Technology plans to sell idle factory assets for a total price of 23.852 million yuan [16] Group 7 - Ganyue Expressway reported a service income of 313 million yuan in September [18] - Dong'an Power secured five new market agreements in the third quarter, with a total projected sales volume of approximately 1 million units [20] Group 8 - Zhongmin Energy achieved a cumulative power generation of 1.922 billion kWh, a year-on-year increase of 1.25% [21] - Pan-Asia Micro-Pore's application for issuing shares to specific objects has been accepted by the Shanghai Stock Exchange [23] Group 9 - Shenghui Integration reported an order balance of 2.214 billion yuan as of September 30, a year-on-year increase of 21.21% [24] - Jineng Technology's vice president resigned for personal reasons [25] Group 10 - Ruixin Microelectronics expects a net profit increase of 116% to 127% for the first three quarters, with a projected profit of 760 million to 800 million yuan [33] - Shanghai Pharmaceuticals received FDA approval for a new drug application for doxycycline capsules [34] Group 11 - Ruima Precision's subsidiary received a project notification for air suspension systems from a domestic automaker, with a total sales forecast of approximately 265 million yuan [36] - Galaxy Magnetics anticipates some impact on its export business due to the Ministry of Commerce's announcement on export controls for certain rare earth items [37] Group 12 - Ba Tian Co. expects a net profit increase of 230.79% to 260.15% for the first three quarters, with a projected profit of 676 million to 736 million yuan [43] - Donglai Technology plans to reduce its repurchased shares by up to 1% of the total share capital [45] Group 13 - Guangkang Biochemical announced that shareholders plan to reduce their holdings by up to 2.68% of the company's shares [46] - Nanwang Energy reported a net profit increase of 37.13% for the first three quarters, with a total revenue of 5.32 billion yuan [48] Group 14 - Yahua Group expects a net profit increase of 106.97% to 132.84% for the first three quarters, with a projected profit of 320 million to 360 million yuan [49] - Hualitai's annual production project for 20,000 tons of benzidine has been successfully completed and is now in full production [51]